Literature DB >> 4490663

Bioavailability of methaqualone.

R D Smyth, J K Lee, A Polk, P B Chemburkar, A M Savacool.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4490663     DOI： 10.1002/j.1552-4604.1973.tb00185.x

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN： 0091-2700            Impact factor:   3.126


× No keyword cloud information.
  5 in total

1.  Serum concentrations of methaqualone after repeated oral doses of a combination formulation to human subjects.

Authors:  C White; E Doyle; L F Chasseaud; T Taylor
Journal:  Eur J Clin Pharmacol       Date:  1976-09-30       Impact factor: 2.953

2.  Methaqualone pharmacokinetics after single- and multiple-dose administration in man.

Authors:  R K Nayak; R D Smyth; J H Chamberlain; A Polk; A F DeLong; T Herczeg; P B Chemburkar; R S Joslin; N H Reavey-Cantwell
Journal:  J Pharmacokinet Biopharm       Date:  1974-04

3.  Metabolic oxidation of methaqualone in extensive and poor metabolisers of debrisoquine.

Authors:  M Oram; K Wilson; D Burnett; S G Al-Dabbagh; J R Idle; R L Smith
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

4.  The kinetics of the urinary excretion of the N-oxide and glucuronides of methaqualone in man.

Authors:  K Wilson; D Burnett; M Oram; C T Reynolds
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1981       Impact factor: 2.441

5.  The metabolism of methaqualone in patients with biliary cirrhosis or secondary carcinoma of the liver.

Authors:  D Burnett; C N Reynolds; K Wilson
Journal:  Eur J Clin Pharmacol       Date:  1979-02-19       Impact factor: 2.953
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.